Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Forrest

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Brain : a Journal of Neurology|December 19, 2017
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathiesShelley L Forrest, Jillian J Kril, Claire H Stevens, et al.
Leukemia & Lymphoma|August 23, 2006
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemiaM J Greenwood, M D Seftel, C Richardson, et al.
European Journal of Neurology|April 1, 2021
Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosisShelley L Forrest, Jordan Hanxi Kim, Clair De Sousa, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 3, 2021
Lr80: A new and widely effective source of leaf rust resistance of wheat for enhancing diversity of resistance among modern cultivarsSubodh Kumar, Subhash C Bhardwaj, Om P Gangwar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.
Blood|September 10, 1998
Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantationT J Nevill, H C Fung, J D Shepherd, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Brain : a Journal of Neurology|December 19, 2017
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathiesShelley L Forrest, Jillian J Kril, Claire H Stevens, et al.
Leukemia & Lymphoma|August 23, 2006
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemiaM J Greenwood, M D Seftel, C Richardson, et al.
European Journal of Neurology|April 1, 2021
Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosisShelley L Forrest, Jordan Hanxi Kim, Clair De Sousa, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 3, 2021
Lr80: A new and widely effective source of leaf rust resistance of wheat for enhancing diversity of resistance among modern cultivarsSubodh Kumar, Subhash C Bhardwaj, Om P Gangwar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.
Blood|September 10, 1998
Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantationT J Nevill, H C Fung, J D Shepherd, et al.
Pageof 36